|
44 Companies |
|
73 Products |
|
73 Products |
|
66 Mechanisms of Action |
|
11 Trials |
|
2460 News |
|
| «12345678910111213...4950» |
- || Trial primary completion date: RPM-CIED: Remote Patient Management for Cardiac Implantable Electronic Devices (clinicaltrials.gov) - Jan 9, 2018
P=N/A, N=400, Recruiting, Sponsor: Ratika Parkash
Trial primary completion date: Jan 2018 --> May 2019
- Enrollment change: VICTORY-AF: Evaluation of the Phased Radio Frequency Ablation System (clinicaltrials.gov) - Jan 9, 2018
P=N/A, N=199, Terminated, Sponsor: Medtronic Atrial Fibrillation Solutions
Trial primary completion date: Jan 2018 --> May 2019 N=300 --> 199
- | Trial primary completion date: PROACTIA: Prediction and Detection of Occult Atrial Fibrillation in Patients After Acute Cryptogenic Stroke and TIA (clinicaltrials.gov) - Jan 9, 2018
P=N/A, N=250, Recruiting, Sponsor: University Hospital, Akershus
N=300 --> 199 Trial primary completion date: Dec 2017 --> Jun 2018
- ||| dabigatran etexilate / Generic mfg.
Trial completion, Adherence: Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF) (clinicaltrials.gov) - Jan 5, 2018
P=N/A, N=1506, Completed, Sponsor: Boehringer Ingelheim
Trial primary completion date: Dec 2017 --> Jun 2018 Active, not recruiting --> Completed
- |||| Trial completion: Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS) (clinicaltrials.gov) - Dec 21, 2017
P4, N=402, Completed, Sponsor: Medtronic Atrial Fibrillation Solutions
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Trial initiation date: E20PC: Electrical Signal Collection From a 20 Pole Catheter During Routine Cardiac Procedures (clinicaltrials.gov) - Dec 20, 2017
P=N/A, N=31, Completed, Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Active, not recruiting --> Completed Enrolling by invitation --> Completed | Initiation date: Sep 2014 --> Oct 2013
- ||| New trial: Analysis of the Acceptance and Changes to Parameters Programming Suggested by the TherapyGuide Function (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=700, Completed, Sponsor: Medtronic Bakken Research Center
- | Trial initiation date, Trial primary completion date: Low Versus High Dose Magnesium Sulfate in the Early Management of Rapid Atrial Fibrillation (clinicaltrials.gov) - Dec 15, 2017
P3, N=450, Completed, Sponsor: University of Monastir
Enrolling by invitation --> Completed | Initiation date: Sep 2014 --> Oct 2013 Initiation date: Aug 2009 --> Nov 2009 | Trial primary completion date: Dec 2014 --> Apr 2014
- | Enrollment change, Trial withdrawal: Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone vs Hybrid Ablation With PVI Plus Catheter Ablation (clinicaltrials.gov) - Dec 15, 2017
P=N/A, N=0, Withdrawn, Sponsor: Jasbir Sra
Initiation date: Aug 2009 --> Nov 2009 | Trial primary completion date: Dec 2014 --> Apr 2014 N=254 --> 0 | Recruiting --> Withdrawn
- | Enrollment change, Trial termination, Trial primary completion date: Comparison of PVI Plus Catheter Ablation or PVI Alone for the Treatment of AFib for Patients With Paroxysmal Atrial Fibrillation (clinicaltrials.gov) - Dec 15, 2017
P=N/A, N=2, Terminated, Sponsor: Aurora Health Care
N=254 --> 0 | Recruiting --> Withdrawn N=284 --> 2 | Recruiting --> Terminated | Trial primary completion date: Mar 2020 --> Aug 2017; Patients did not want to be randomized in their procedure.
- | Trial completion: iRead: Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation (clinicaltrials.gov) - Dec 13, 2017
P=N/A, N=60, Completed, Sponsor: The Cleveland Clinic
N=284 --> 2 | Recruiting --> Terminated | Trial primary completion date: Mar 2020 --> Aug 2017; Patients did not want to be randomized in their procedure. Active, not recruiting --> Completed
- | Trial completion: DETECTAF-pro: Enhanced Diagnostics for Early Detection of Atrial Fibrillation - Prospective Validation (clinicaltrials.gov) - Dec 13, 2017
P=N/A, N=672, Completed, Sponsor: University Hospital, Basel, Switzerland
Active, not recruiting --> Completed Recruiting --> Completed
- || Trial primary completion date: CLASS-AF: Clinical and Laboratory Predictors Associated With Stroke or Systemic Embolism in Low Risk Atrial Fibrillation Patients (clinicaltrials.gov) - Dec 12, 2017
P=N/A, N=1000, Recruiting, Sponsor: Korea University Guro Hospital
Recruiting --> Completed Trial primary completion date: Apr 2018 --> Jan 2018
- | Trial completion, Enrollment change: Maestro Handheld Cardiac Monitor Validation (clinicaltrials.gov) - Dec 8, 2017
P=N/A, N=70, Completed, Sponsor: University of Michigan
Trial primary completion date: Apr 2018 --> Jan 2018 Active, not recruiting --> Completed | N=150 --> 70
- | flecainide / Generic mfg.
Trial completion, Trial primary completion date: Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome (clinicaltrials.gov) - Dec 6, 2017
P1/2, N=206, Completed, Sponsor: New York University School of Medicine
Active, not recruiting --> Completed | N=150 --> 70 Recruiting --> Completed | Trial primary completion date: Jan 2018 --> Jul 2017
- | Trial completion: Study of the Wearable Defibrillator in Heart-Failure Patients (clinicaltrials.gov) - Dec 6, 2017
P=N/A, N=25, Completed, Sponsor: Zoll Medical Corporation
Recruiting --> Completed | Trial primary completion date: Jan 2018 --> Jul 2017 Active, not recruiting --> Completed
- || Enrollment closed, Enrollment change, Trial primary completion date: ELITE: Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients (clinicaltrials.gov) - Dec 4, 2017
P=N/A, N=251, Active, not recruiting, Sponsor: Duke University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=500 --> 251 | Trial primary completion date: Dec 2017 --> May 2018
- | Trial completion: Dipole Density Mapping in Supraventricular Tachycardia (clinicaltrials.gov) - Dec 2, 2017
P=N/A, N=29, Completed, Sponsor: Acutus Medical
Recruiting --> Active, not recruiting | N=500 --> 251 | Trial primary completion date: Dec 2017 --> May 2018 Active, not recruiting --> Completed
- | Enrollment closed: Maestro Handheld Cardiac Monitor Validation (clinicaltrials.gov) - Dec 2, 2017
P=N/A, N=150, Active, not recruiting, Sponsor: University of Michigan
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Trial completion, Trial primary completion date: Pacing in First-degree AV-block (clinicaltrials.gov) - Nov 30, 2017
P=N/A, N=20, Completed, Sponsor: Duke University
Recruiting --> Active, not recruiting Recruiting --> Completed | Trial primary completion date: Jun 2018 --> Oct 2017
- | Trial primary completion date: Study to Monitor Patients With Pacemakers or ICDs Who Undergo MRI Scans (clinicaltrials.gov) - Nov 29, 2017
P=N/A, N=500, Active, not recruiting, Sponsor: Essentia Health
Recruiting --> Completed | Trial primary completion date: Jun 2018 --> Oct 2017 Trial primary completion date: Oct 2017 --> Oct 2018
- | Trial completion, Trial primary completion date: RYTHMODIAL: Implantable Loop Recorder in Hemodialysis Patients (clinicaltrials.gov) - Nov 27, 2017
P=N/A, N=72, Completed, Sponsor: University Hospital, Bordeaux
Trial primary completion date: Oct 2017 --> Oct 2018 Active, not recruiting --> Completed | Trial primary completion date: Nov 2015 --> Feb 2016
- | Trial completion: STAR: Prospective Physician-Initiated Observational Study of The Contact Detection System (CDS) in Patients Undergoing Radiofrequency Ablation Using the Niobe (clinicaltrials.gov) - Nov 27, 2017
P=N/A, N=30, Completed, Sponsor: Erasmus Medical Center
Active, not recruiting --> Completed | Trial primary completion date: Nov 2015 --> Feb 2016 Recruiting --> Completed
- || Trial primary completion date: TAVI/LAAO: Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in AF Undergoing TAVI (clinicaltrials.gov) - Nov 21, 2017
P=N/A, N=80, Recruiting, Sponsor: University of Zurich
Recruiting --> Completed Trial primary completion date: May 2017 --> May 2018
- | Trial completion, Trial initiation date: CROMIS-2: Clinical Relevance of Microbleeds In Stroke (clinicaltrials.gov) - Nov 17, 2017
P=N/A, N=2490, Completed, Sponsor: University College, London
Trial primary completion date: May 2017 --> May 2018 Active, not recruiting --> Completed | Initiation date: Oct 2010 --> Aug 2011
- | Trial completion: Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF (clinicaltrials.gov) - Nov 17, 2017
P=N/A, N=91, Completed, Sponsor: Medical University of Graz
Active, not recruiting --> Completed | Initiation date: Oct 2010 --> Aug 2011 Active, not recruiting --> Completed
- | Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Enrollment closed, Surgery: Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery (clinicaltrials.gov) - Nov 14, 2017
P1/2, N=130, Active, not recruiting, Sponsor: Joseph Mathew, M.D.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||| Trial completion: IMPACT-AFt: Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation (clinicaltrials.gov) - Nov 13, 2017
P=N/A, N=2374, Completed, Sponsor: Duke University
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Trial primary completion date: Cardiac Arrhythmias in Dravet Syndrome (clinicaltrials.gov) - Nov 8, 2017
P=N/A, N=60, Recruiting, Sponsor: Stichting Epilepsie Instellingen Nederland
Active, not recruiting --> Completed Trial primary completion date: Aug 2017 --> Aug 2018
- | dabigatran etexilate / Generic mfg.
Enrollment change, Trial initiation date, Trial primary completion date: DAPPARAF: DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation (clinicaltrials.gov) - Nov 6, 2017
P4, N=50, Completed, Sponsor: Lawson Health Research Institute
Trial primary completion date: Aug 2017 --> Aug 2018 N=200 --> 50 | Initiation date: Nov 2011 --> Jul 2011 | Trial primary completion date: Jan 2014 --> Jan 2017
- | warfarin / Generic mfg.
Biomarker, Phase classification: Genotype-guided Warfarin Individualized Treatment (clinicaltrials.gov) - Nov 6, 2017
P=N/A, N=660, Completed, Sponsor: The Third Xiangya Hospital of Central South University
N=200 --> 50 | Initiation date: Nov 2011 --> Jul 2011 | Trial primary completion date: Jan 2014 --> Jan 2017 Phase classification: P4 --> P=N/A
- || Trial primary completion date, HEOR: RE-QoL: Health-related Quality of Life in Patients on Anticoagulants (clinicaltrials.gov) - Nov 1, 2017
P=N/A, N=500, Recruiting, Sponsor: Boehringer Ingelheim
Phase classification: P4 --> P=N/A Trial primary completion date: Oct 2017 --> Jan 2018
- ||| apixaban / Generic mfg.
Trial completion: Eliquis Regulatory Post Marketing Surveillance (clinicaltrials.gov) - Oct 31, 2017
P=N/A, N=3335, Completed, Sponsor: Bristol-Myers Squibb
Trial primary completion date: Oct 2017 --> Jan 2018 Active, not recruiting --> Completed
- ||| Trial completion: SPRINT-AF: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (clinicaltrials.gov) - Oct 27, 2017
P=N/A, N=2499, Completed, Sponsor: Canadian Collaborative Research Network
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Enrollment change: Predicting Fluid Responsiveness in on Pump Coronary Artery Bypass Graft Using Extra Systoles (clinicaltrials.gov) - Oct 27, 2017
P=N/A, N=95, Completed, Sponsor: University of Aarhus
Active, not recruiting --> Completed Recruiting --> Completed | N=60 --> 95
- | Trial primary completion date: HEMOPTICS2: Assessment of a Diagnostic Medical Device for the INR (International Normalized Ratio) Measurement (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=200, Recruiting, Sponsor: University Hospital, Grenoble
Recruiting --> Completed | N=60 --> 95 Trial primary completion date: May 2017 --> Jun 2018
- | Trial initiation date: Proper Extent of Maze Intercaval Lesion (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=50, Not yet recruiting, Sponsor: Baylor Research Institute
Trial primary completion date: May 2017 --> Jun 2018 Initiation date: Aug 2017 --> Dec 2017
- | Infanrix (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed) / GSK, PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
Trial completion: Effect of Morning vs. Evening Vaccination on Hypoxia and Bradycardia of Preterm Infants: a Randomised Controled Trial (clinicaltrials.gov) - Oct 25, 2017
P3, N=16, Completed, Sponsor: University Hospital Tuebingen
Initiation date: Aug 2017 --> Dec 2017 Active, not recruiting --> Completed
- |||| apixaban / Generic mfg.
Trial completion: AXAFA: Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy (clinicaltrials.gov) - Oct 20, 2017
P4, N=676, Completed, Sponsor: German Atrial Fibrillation Network
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Trial completion: Cryoballoon Ablation for Early Persistent Atrial Fibrillation (Cryo4 Persistent AF) (clinicaltrials.gov) - Oct 20, 2017
P=N/A, N=130, Completed, Sponsor: Medtronic Atrial Fibrillation Solutions
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation (clinicaltrials.gov) - Oct 19, 2017
P=N/A, N=400, Completed, Sponsor: Texas Cardiac Arrhythmia Research Foundation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Biomarker, Trial completion: IMPACTII: Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation (clinicaltrials.gov) - Oct 19, 2017
P=N/A, N=155, Completed, Sponsor: Texas Cardiac Arrhythmia Research Foundation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: OASIS: Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation (clinicaltrials.gov) - Oct 19, 2017
P3, N=120, Completed, Sponsor: Texas Cardiac Arrhythmia Research Foundation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Trial primary completion date, Surgery: Atrial Fibrillation After Cardiac Surgery-comparing Conventional and Miniaturized Bypass Systems (clinicaltrials.gov) - Oct 18, 2017
P=N/A, N=240, Completed, Sponsor: Kuopio University Hospital
Active, not recruiting --> Completed Recruiting --> Completed | N=330 --> 240 | Trial primary completion date: Sep 2017 --> Jul 2016
- ||| Trial completion: PRECISE: Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode (clinicaltrials.gov) - Oct 18, 2017
P=N/A, N=848, Completed, Sponsor: LivaNova
Recruiting --> Completed | N=330 --> 240 | Trial primary completion date: Sep 2017 --> Jul 2016 Active, not recruiting --> Completed
- | Trial primary completion date: The Contact-CTI Study: Use of Tissue Contact Data to Guide Atrial Flutter Ablation (clinicaltrials.gov) - Oct 13, 2017
P4, N=101, Completed, Sponsor: Oxford University Hospitals NHS Trust
Active, not recruiting --> Completed Trial primary completion date: Dec 2012 --> Apr 2013
- || Savaysa (edoxaban) / Daiichi Sankyo
Enrollment closed: Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes (clinicaltrials.gov) - Oct 12, 2017
P=N/A, N=607, Active, not recruiting, Sponsor: Daiichi Sankyo, Inc.
Trial primary completion date: Dec 2012 --> Apr 2013 Recruiting --> Active, not recruiting
- || rivaroxaban / Generic mfg.
Enrollment closed: X-PRESS: Xarelto Evidence in Real Life of Patients' Preference and Satisfaction Study (clinicaltrials.gov) - Oct 12, 2017
P=N/A, N=255, Active, not recruiting, Sponsor: Bayer
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | Trial completion: Pacific: Atrial Fibrillation and Premature Atrial Complexes in Patients With Ischemic Stroke. (clinicaltrials.gov) - Oct 11, 2017
P=N/A, N=264, Completed, Sponsor: Odense University Hospital
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Trial primary completion date: The Renin-Aldosterone Axis in Postural Tachycardia Syndrome (clinicaltrials.gov) - Oct 6, 2017
P=N/A, N=35, Completed, Sponsor: Vanderbilt University Medical Center
Active, not recruiting --> Completed Recruiting --> Completed | N=18 --> 35 | Trial primary completion date: Apr 2011 --> Dec 2012